Easy Access and Express Report Delivery Service
Hereditary Disease Testing Market, Global Outlook and Forecast 2023-2029
Report ID
35559
Publisher
Market Monitor Global
Published Date
17-Oct
Delivery Format
PDF
No of Report Page
103
Editor's Rating
-
Report Details
This research report provides a comprehensive analysis of the Hereditary Disease Testing market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Hereditary Disease Testing market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Hereditary Disease Testing, challenges faced by the industry, and potential opportunities for market players. The global Hereditary Disease Testing market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Hereditary Disease Testing market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Hereditary Disease Testing market. Additionally, the growing consumer demand present avenues for market expansion. The global Hereditary Disease Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Key Features: The research report on the Hereditary Disease Testing market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders. Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Hereditary Disease Testing market. Market Overview: The report provides a comprehensive overview of the Hereditary Disease Testing market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Hereditary Cancer Testing, Hereditary Non-cancer Testing), region, and application, highlighting the key drivers, challenges, and opportunities within each segment. Market Dynamics: The report analyses the market dynamics driving the growth and development of the Hereditary Disease Testing market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Hereditary Disease Testing market's trajectory. Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Hereditary Disease Testing market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. Market Segmentation and Forecast: The report segment the Hereditary Disease Testing market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions. Technological Trends: The report should highlight the key technological trends shaping the Hereditary Disease Testing market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences. Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Hereditary Disease Testing market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders. Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Hereditary Disease Testing, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments. Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Hereditary Disease Testing market. Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts. Market Segmentation Hereditary Disease Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value. Market segment by Type Hereditary Cancer Testing Hereditary Non-cancer Testing Market segment by Application Hospital Clinic Laboratory Others Global Hereditary Disease Testing Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Major players covered Myriad Genetics Invitae Illumina Natera Laboratory Corporation of America Holdings F. Hoffmann-La Roche Quest Diagnostics CooperSurgical Agilent Technologies Thermo Fisher Scientific Twist Bioscience Sophia Genetics Fulgent Genetic Medgenome CENTOGENE Outline of Major Chapters: Chapter 1: Introduces the definition of Hereditary Disease Testing, market overview. Chapter 2: Global Hereditary Disease Testing market size in revenue. Chapter 3: Detailed analysis of Hereditary Disease Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Hereditary Disease Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: The main points and conclusions of the report. -
Table Of Content
1 Introduction to Research & Analysis Reports 1.1 Hereditary Disease Testing Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Hereditary Disease Testing Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Hereditary Disease Testing Overall Market Size 2.1 Global Hereditary Disease Testing Market Size: 2022 VS 2029 2.2 Global Hereditary Disease Testing Market Size, Prospects & Forecasts: 2018-2029 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Hereditary Disease Testing Players in Global Market 3.2 Top Global Hereditary Disease Testing Companies Ranked by Revenue 3.3 Global Hereditary Disease Testing Revenue by Companies 3.4 Top 3 and Top 5 Hereditary Disease Testing Companies in Global Market, by Revenue in 2022 3.5 Global Companies Hereditary Disease Testing Product Type 3.6 Tier 1, Tier 2 and Tier 3 Hereditary Disease Testing Players in Global Market 3.6.1 List of Global Tier 1 Hereditary Disease Testing Companies 3.6.2 List of Global Tier 2 and Tier 3 Hereditary Disease Testing Companies 4 Market Sights by Product 4.1 Overview 4.1.1 By Type - Global Hereditary Disease Testing Market Size Markets, 2022 & 2029 4.1.2 Hereditary Cancer Testing 4.1.3 Hereditary Non-cancer Testing 4.2 By Type - Global Hereditary Disease Testing Revenue & Forecasts 4.2.1 By Type - Global Hereditary Disease Testing Revenue, 2018-2023 4.2.2 By Type - Global Hereditary Disease Testing Revenue, 2024-2029 4.2.3 By Type - Global Hereditary Disease Testing Revenue Market Share, 2018-2029 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Hereditary Disease Testing Market Size, 2022 & 2029 5.1.2 Hospital 5.1.3 Clinic 5.1.4 Laboratory 5.1.5 Others 5.2 By Application - Global Hereditary Disease Testing Revenue & Forecasts 5.2.1 By Application - Global Hereditary Disease Testing Revenue, 2018-2023 5.2.2 By Application - Global Hereditary Disease Testing Revenue, 2024-2029 5.2.3 By Application - Global Hereditary Disease Testing Revenue Market Share, 2018-2029 6 Sights by Region 6.1 By Region - Global Hereditary Disease Testing Market Size, 2022 & 2029 6.2 By Region - Global Hereditary Disease Testing Revenue & Forecasts 6.2.1 By Region - Global Hereditary Disease Testing Revenue, 2018-2023 6.2.2 By Region - Global Hereditary Disease Testing Revenue, 2024-2029 6.2.3 By Region - Global Hereditary Disease Testing Revenue Market Share, 2018-2029 6.3 North America 6.3.1 By Country - North America Hereditary Disease Testing Revenue, 2018-2029 6.3.2 US Hereditary Disease Testing Market Size, 2018-2029 6.3.3 Canada Hereditary Disease Testing Market Size, 2018-2029 6.3.4 Mexico Hereditary Disease Testing Market Size, 2018-2029 6.4 Europe 6.4.1 By Country - Europe Hereditary Disease Testing Revenue, 2018-2029 6.4.2 Germany Hereditary Disease Testing Market Size, 2018-2029 6.4.3 France Hereditary Disease Testing Market Size, 2018-2029 6.4.4 U.K. Hereditary Disease Testing Market Size, 2018-2029 6.4.5 Italy Hereditary Disease Testing Market Size, 2018-2029 6.4.6 Russia Hereditary Disease Testing Market Size, 2018-2029 6.4.7 Nordic Countries Hereditary Disease Testing Market Size, 2018-2029 6.4.8 Benelux Hereditary Disease Testing Market Size, 2018-2029 6.5 Asia 6.5.1 By Region - Asia Hereditary Disease Testing Revenue, 2018-2029 6.5.2 China Hereditary Disease Testing Market Size, 2018-2029 6.5.3 Japan Hereditary Disease Testing Market Size, 2018-2029 6.5.4 South Korea Hereditary Disease Testing Market Size, 2018-2029 6.5.5 Southeast Asia Hereditary Disease Testing Market Size, 2018-2029 6.5.6 India Hereditary Disease Testing Market Size, 2018-2029 6.6 South America 6.6.1 By Country - South America Hereditary Disease Testing Revenue, 2018-2029 6.6.2 Brazil Hereditary Disease Testing Market Size, 2018-2029 6.6.3 Argentina Hereditary Disease Testing Market Size, 2018-2029 6.7 Middle East & Africa 6.7.1 By Country - Middle East & Africa Hereditary Disease Testing Revenue, 2018-2029 6.7.2 Turkey Hereditary Disease Testing Market Size, 2018-2029 6.7.3 Israel Hereditary Disease Testing Market Size, 2018-2029 6.7.4 Saudi Arabia Hereditary Disease Testing Market Size, 2018-2029 6.7.5 UAE Hereditary Disease Testing Market Size, 2018-2029 7 Hereditary Disease Testing Companies Profiles 7.1 Myriad Genetics 7.1.1 Myriad Genetics Company Summary 7.1.2 Myriad Genetics Business Overview 7.1.3 Myriad Genetics Hereditary Disease Testing Major Product Offerings 7.1.4 Myriad Genetics Hereditary Disease Testing Revenue in Global Market (2018-2023) 7.1.5 Myriad Genetics Key News & Latest Developments 7.2 Invitae 7.2.1 Invitae Company Summary 7.2.2 Invitae Business Overview 7.2.3 Invitae Hereditary Disease Testing Major Product Offerings 7.2.4 Invitae Hereditary Disease Testing Revenue in Global Market (2018-2023) 7.2.5 Invitae Key News & Latest Developments 7.3 Illumina 7.3.1 Illumina Company Summary 7.3.2 Illumina Business Overview 7.3.3 Illumina Hereditary Disease Testing Major Product Offerings 7.3.4 Illumina Hereditary Disease Testing Revenue in Global Market (2018-2023) 7.3.5 Illumina Key News & Latest Developments 7.4 Natera 7.4.1 Natera Company Summary 7.4.2 Natera Business Overview 7.4.3 Natera Hereditary Disease Testing Major Product Offerings 7.4.4 Natera Hereditary Disease Testing Revenue in Global Market (2018-2023) 7.4.5 Natera Key News & Latest Developments 7.5 Laboratory Corporation of America Holdings 7.5.1 Laboratory Corporation of America Holdings Company Summary 7.5.2 Laboratory Corporation of America Holdings Business Overview 7.5.3 Laboratory Corporation of America Holdings Hereditary Disease Testing Major Product Offerings 7.5.4 Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue in Global Market (2018-2023) 7.5.5 Laboratory Corporation of America Holdings Key News & Latest Developments 7.6 F. Hoffmann-La Roche 7.6.1 F. Hoffmann-La Roche Company Summary 7.6.2 F. Hoffmann-La Roche Business Overview 7.6.3 F. Hoffmann-La Roche Hereditary Disease Testing Major Product Offerings 7.6.4 F. Hoffmann-La Roche Hereditary Disease Testing Revenue in Global Market (2018-2023) 7.6.5 F. Hoffmann-La Roche Key News & Latest Developments 7.7 Quest Diagnostics 7.7.1 Quest Diagnostics Company Summary 7.7.2 Quest Diagnostics Business Overview 7.7.3 Quest Diagnostics Hereditary Disease Testing Major Product Offerings 7.7.4 Quest Diagnostics Hereditary Disease Testing Revenue in Global Market (2018-2023) 7.7.5 Quest Diagnostics Key News & Latest Developments 7.8 CooperSurgical 7.8.1 CooperSurgical Company Summary 7.8.2 CooperSurgical Business Overview 7.8.3 CooperSurgical Hereditary Disease Testing Major Product Offerings 7.8.4 CooperSurgical Hereditary Disease Testing Revenue in Global Market (2018-2023) 7.8.5 CooperSurgical Key News & Latest Developments 7.9 Agilent Technologies 7.9.1 Agilent Technologies Company Summary 7.9.2 Agilent Technologies Business Overview 7.9.3 Agilent Technologies Hereditary Disease Testing Major Product Offerings 7.9.4 Agilent Technologies Hereditary Disease Testing Revenue in Global Market (2018-2023) 7.9.5 Agilent Technologies Key News & Latest Developments 7.10 Thermo Fisher Scientific 7.10.1 Thermo Fisher Scientific Company Summary 7.10.2 Thermo Fisher Scientific Business Overview 7.10.3 Thermo Fisher Scientific Hereditary Disease Testing Major Product Offerings 7.10.4 Thermo Fisher Scientific Hereditary Disease Testing Revenue in Global Market (2018-2023) 7.10.5 Thermo Fisher Scientific Key News & Latest Developments 7.11 Twist Bioscience 7.11.1 Twist Bioscience Company Summary 7.11.2 Twist Bioscience Business Overview 7.11.3 Twist Bioscience Hereditary Disease Testing Major Product Offerings 7.11.4 Twist Bioscience Hereditary Disease Testing Revenue in Global Market (2018-2023) 7.11.5 Twist Bioscience Key News & Latest Developments 7.12 Sophia Genetics 7.12.1 Sophia Genetics Company Summary 7.12.2 Sophia Genetics Business Overview 7.12.3 Sophia Genetics Hereditary Disease Testing Major Product Offerings 7.12.4 Sophia Genetics Hereditary Disease Testing Revenue in Global Market (2018-2023) 7.12.5 Sophia Genetics Key News & Latest Developments 7.13 Fulgent Genetic 7.13.1 Fulgent Genetic Company Summary 7.13.2 Fulgent Genetic Business Overview 7.13.3 Fulgent Genetic Hereditary Disease Testing Major Product Offerings 7.13.4 Fulgent Genetic Hereditary Disease Testing Revenue in Global Market (2018-2023) 7.13.5 Fulgent Genetic Key News & Latest Developments 7.14 Medgenome 7.14.1 Medgenome Company Summary 7.14.2 Medgenome Business Overview 7.14.3 Medgenome Hereditary Disease Testing Major Product Offerings 7.14.4 Medgenome Hereditary Disease Testing Revenue in Global Market (2018-2023) 7.14.5 Medgenome Key News & Latest Developments 7.15 CENTOGENE 7.15.1 CENTOGENE Company Summary 7.15.2 CENTOGENE Business Overview 7.15.3 CENTOGENE Hereditary Disease Testing Major Product Offerings 7.15.4 CENTOGENE Hereditary Disease Testing Revenue in Global Market (2018-2023) 7.15.5 CENTOGENE Key News & Latest Developments 8 Conclusion 9 Appendix 9.1 Note 9.2 Examples of Clients 9.3 Disclaimer -
Inquiry Before Buying
WHY CHOOSE US
Discover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday -
Request Sample
WHY CHOOSE US
Easy Access and Express Report Delivery ServiceDiscover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday
